NIH-funded research R01 grant

Identifying targets for treating a specific type of heart arrhythmia.

Official title: Multiomics and Functional Characterization Establish Druggable Targets for PVC-Driven Idiopathic VF

Funded at University of Wisconsin-Madison · NIH-10873297 · Data updated 2026-11-12

This study is looking into a type of heart rhythm problem called Idiopathic Ventricular Fibrillation (IVF) to better understand how it works, and it's inviting patients with this condition to help by providing cells that can be studied in the lab, which could lead to better and more personalized treatments for them.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startJuly 1, 2023
Project endJune 30, 2027
Funding year2024
Award (this year)$749,641
NIH project number5R01HL170521-02
Project IDNIH-10873297 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with idiopathic ventricular fibrillation, particularly those who do not fit existing diagnostic criteria.

Less likely to help

Patients with well-defined arrhythmia syndromes or those who do not have idiopathic ventricular fibrillation may not benefit from this research.

What this research studies

This research focuses on understanding a type of heart arrhythmia known as Idiopathic Ventricular Fibrillation (IVF), which affects many individuals without clear diagnostic criteria. By integrating advanced computational modeling and multiomic data, the study aims to uncover the underlying mechanisms of a specific subphenotype of IVF related to Purkinje-triggered ventricular fibrillation. Patients with this condition will be recruited to create induced pluripotent stem cells (iPSCs), allowing researchers to study heart cells in a lab setting. This approach could lead to more personalized and effective treatment options for those affected by this arrhythmia.

Why it matters

Potential benefit: If successful, this research could lead to targeted therapies that significantly improve outcomes for patients with idiopathic ventricular fibrillation.

How similar studies have gone: While there has been significant research into arrhythmias, this specific approach integrating multiomics and computational modeling for IVF is relatively novel and has not been extensively tested.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Eckhardt, Lee Lochbaum — University of Wisconsin-Madison
  • Study coordinator: Eckhardt, Lee Lochbaum

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.